Creating Better Cells for Regenerative Medicine
TR&D-1: Cell Fabrication
This research aims to develop new ways to grow and prepare human cells automatically, making them more effective for future medical treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Case Western Reserve University NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-11123250 on NIH RePORTER |
What this research studies
Our goal is to create advanced technologies and methods for growing cells in a lab that are perfectly suited for regenerative medicine and tissue repair. Currently, it's hard to get cells with consistent qualities because of differences between donors and a lack of understanding about how cells react to their environment. We plan to overcome these challenges by using special sensors that track cell behavior in real-time and by making targeted changes to cells to ensure they have the desired characteristics. While starting with human stem cells, these strategies can be applied to many types of cells to improve future therapies.
Who could benefit from this research
Good fit: Patients who might benefit from future regenerative medicine treatments, such as those needing tissue repair or replacement, are the ultimate beneficiaries of this foundational work.
Not a fit: Patients whose conditions are not addressed by cell-based or regenerative medicine therapies would not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to more reliable and effective cell-based therapies for a wide range of conditions, making regenerative medicine more accessible and predictable.
How similar studies have performed: This research focuses on developing novel technologies and strategies for cell fabrication, building upon existing knowledge but pushing into new areas of automation and control.
Where this research is happening
Cleveland, United States
- Case Western Reserve University — Cleveland, United States (Active)
Researchers
- Principal investigator: Somoza, Rodrigo Alfonso — Case Western Reserve University
- Study coordinator: Somoza, Rodrigo Alfonso
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.